Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Henry Zall
Chemotherapeutic Drugs Sensitize Human Renal Cell Carcinoma Cells to ABT-737 by a Mechanism Involving the Noxa-Dependent Inactivation of McL-1 or A1
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Related publications
The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells
Cancer Cell International
Cancer Research
Oncology
Genetics
Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
McL-1 Down-Regulation Potentiates ABT-737 Lethality by Cooperatively Inducing Bak Activation and Bax Translocation
Cancer Research
Cancer Research
Oncology
Monosaccharide Digitoxin Derivative Sensitize Human Non-Small Cell Lung Cancer Cells to Anoikis Through McL-1 Proteasomal Degradation
Biochemical Pharmacology
Biochemistry
Pharmacology
ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells With a BCL-2high/McL-1low Profile and Synergizes With Other Antineoplastic Agents
Clinical Cancer Research
Cancer Research
Oncology
1 H NMR Metabolomics Analysis of Renal Cell Carcinoma Cells: Effect of VHL Inactivation on Metabolism
International Journal of Cancer
Cancer Research
Oncology
Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A
Apoptosis : an international journal on programmed cell death
Cell Biology
Pharmacology
Biochemistry
Clinical Biochemistry
Cancer Research
Pharmaceutical Science
Norcantharidin Enhances ABT-263-mediated Anticancer Activity in Neuroblastoma Cells by Upregulation of Noxa
Oncology Reports
Medicine
Cancer Research
Oncology
Interleukin 15–mediated Survival of Natural Killer Cells Is Determined by Interactions Among Bim, Noxa and McL-1
Nature Immunology
Allergy
Immunology
